July 1st 2026 a PR was released by---UNIVEC, Inc. (OTC: UNVC) and 11 Three LLC Announce Advanced Transdermal Neuro-Anesthetic Pain Patch, RELIEFTA™ Quote===This initial announcement marks a critical step forward in our joint commercialization pathway," said Dr. David Dalton, CEO of UNIVEC, Inc. "
Then came the Capital Deck/startup, asking 5-million safe note, switching it to a series A any Structure.... completely changes the investor power dynamic: Slide 7....The Launchpad 90 Days NDC Acquisition Finalize acquisition and trigger national retail distribution within a tight operational window.
Slide 10....Strategic MOU Formalized April 2026 with CentennialRx, securing national pharmacy network access. For national distribution arrangements involving prescription-grade products, compounding, or direct pharmacy network fulfillment (like the CentennialRx MOU), pharmacy laws require a licensed, active Pharmacist-in-Charge (PIC) in the relevant operating states.
The transition to a Series A pitch deck demonstrates that institutional investors are unlikely to hand over 5 million without demanding structural governance, board oversight, and rigorous due diligence into UNVC's financial filings, FDA compliance, and state licensing status...... If the capital raise stalls, the high-level national rollout strategy shrinks down to whatever direct-to-consumer sales 11 Three LLC can generate on its own....leaving the public entity (UNVC) without the institutional backing needed to fund a true national distribution push.
If they don't get any takers in the 5-million startup, the only launch has already taken place.
https://11threetech.com/
PL
Then came the Capital Deck/startup, asking 5-million safe note, switching it to a series A any Structure.... completely changes the investor power dynamic: Slide 7....The Launchpad 90 Days NDC Acquisition Finalize acquisition and trigger national retail distribution within a tight operational window.
Slide 10....Strategic MOU Formalized April 2026 with CentennialRx, securing national pharmacy network access. For national distribution arrangements involving prescription-grade products, compounding, or direct pharmacy network fulfillment (like the CentennialRx MOU), pharmacy laws require a licensed, active Pharmacist-in-Charge (PIC) in the relevant operating states.
The transition to a Series A pitch deck demonstrates that institutional investors are unlikely to hand over 5 million without demanding structural governance, board oversight, and rigorous due diligence into UNVC's financial filings, FDA compliance, and state licensing status...... If the capital raise stalls, the high-level national rollout strategy shrinks down to whatever direct-to-consumer sales 11 Three LLC can generate on its own....leaving the public entity (UNVC) without the institutional backing needed to fund a true national distribution push.
If they don't get any takers in the 5-million startup, the only launch has already taken place.
https://11threetech.com/
PL
1
